Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

Abstract Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerability of onabotulinumtoxinA for headache prevention in adults with chronic migraine. This post hoc analysis evaluated the effect of onabotulinumtoxinA on clinically meaningful changes in headache seve...

Full description

Bibliographic Details
Main Authors: Hans-Christoph Diener, David W. Dodick, Richard B. Lipton, Aubrey Manack Adams, Ronald E. DeGryse, Stephen D. Silberstein
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-10-01
Series:Pain and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40122-020-00198-w